๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dopamine D2agonist priming in intact and dopamine-lesioned rats

โœ Scribed by Richard M. Kostrzewa; John P. Kostrzewa; Przemyslaw Nowak; Rose Anna Kostrzewa; Ryszard Brus

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
117 KB
Volume
6
Category
Article
ISSN
1029-8428

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Role of dopamine D-1 and D-2 receptor su
Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats
โœ M. T. Martin-Iverson; C. T. Dourish ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 556 KB

The effects of selective D-2 and D-1 dopamine (DA) receptor agonists on food consumption were investigated in free-feeding rats. A selective D-2 receptor agonist, (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), increased the consumption of standard food pellets in the dose range of 7.5-120 micrograms/kg

Antiparkinsonian effects of the novel D3
Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors
โœ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept